The Bayer Group had a successful year in 2021, both operationally and strategically. “We posted substantial growth, strengthened our innovation pipeline and made progress toward our sustainability .
iStock/Getty Images In the agricultural business, Bayer increased sales by 1.3%, with business increasing in Latin America, Asia and Pacific regions.
Feb 26, 2021
The Bayer Group has weathered a global pandemic with little visible impact to the bottomline as 2020 earnings before interest, taxes, depreciation and amortization were steady with the prior year at 11.461 billion euros ($14 billion).
Group sales were at 41.400 billion euros ($50.6 billion), impacted by negative currency effects of 1.941 billion euros ($2.4 billion). Core earnings per share were 6.39 euros ($7.80), up .2%, but earnings per share were impacted negatively by litigation and impairments. Net financial debt improved by 11.8% to 30.041 billion euros ($41.6 billion).
“If you factor out the negative currency effects, core earnings per share would have been just under seven euros ($8.60), which is almost the level we had been targeting before the pandemic spread,” said Werner Bauma
Bayer delivers robust performance despite pandemic chemeurope.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chemeurope.com Daily Mail and Mail on Sunday newspapers.